| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |